Come up with a name for your new list and we'll add to it:
certus molecular diagnostics raised a round of funding on May 18, 2017. Investors include
W.A. de Vigier Stiftung.
certus molecular diagnostics is the developer of isoAMP, a highly reliable method for the on-site detection of pathogens such as herpes or influenza viruses within only 30 minutes. This enables an imm…